lobbying_activities: 1554004

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1554004	9066f758-044f-4e67-b60d-40140c585571	Q2	VENABLE LLP	39941	ENDO PHARMACEUTICALS INC	2014	second_quarter	PHA	Issues related to bioequivalence and related administrative procedures; issues related to prescription drug abuse; issues related to the labeling of generic drugs; issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act; Issues relating to Medicare Part D rebates; H.R. 486 Stop Tampering of Prescription Pills Act of 2013; H.R. 1919 Safeguarding Americas Pharmaceuticals Act of 2013	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2014-07-16T18:13:49.103000-04:00